Cancer Drug 'Too Expensive for NHS'

guardian.co.uk — Experts call watchdog's decision on abiraterone a huge blow to men with late-stage prostate cancer. Feb 2, 2012 View in Crawl 4

Cancer Drug 'Too Expensive for NHS'